Findings from a recent study published in the British Journal of Psychiatry revealed that antipsychotic drugs are…
Articles by Ana de Barros, PhD
In a study recently published in the journal Brain a team of researchers found an immune system…
Clinical-stage biopharmaceutical company Anavex Life Sciences Corp. is working on an investigational oral treatment for Alzheimer’s disease called…
Clinical-stage biopharmaceutical company, Axovant Sciences Ltd., recently announced it has screened the first batch of patients for MINDSET, an international…
Results from a recent study conducted by scientists at the Universidad Nacional Autónoma de México, Instituto Nacional de Pediatría, Centro…
According to a new analysis conducted by Alzheimer’s Research UK one in three people born in 2015 will develop Alzheimer’s…
A recent study published this week in Nature has revealed that the “seeds” of Alzheimer’s disease and related…
Results from the largest nationwide study investigating long-term high-dose resveratrol in patients with mild to moderate Alzheimer’s disease (AD)…
A new study from Michigan State University which aims to pinpoint the early signs of Alzheimer’s disease among Latinos and Hispanics,…
Alzheimer’s Disease (AD) has been a topic of extensive research over the past three decades. The main focus of many…